يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Etanercept/administration & dosage"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1

    المساهمون: University of Zurich, Ciurea, Adrian

    المصدر: PLoS ONE
    PloS one, vol. 14, no. 5, pp. e0216746
    PLoS ONE, Vol 14, Iss 5, p e0216746 (2019)
    Hebeisen, Monika; Scherer, Almut; Micheroli, Raphael; Nissen, Michael J; Tamborrini, Giorgio; Möller, Burkhard; Zufferey, Pascal; Exer, Pascale; Ciurea, Adrian (2019). Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. PLoS ONE, 14(5), e0216746. Public Library of Science 10.1371/journal.pone.0216746 <http://dx.doi.org/10.1371/journal.pone.0216746>
    PLOS ONE, Vol. 14, No 5 (2019) P. e0216746

    مصطلحات موضوعية: Male, Time Factors, Physiology, medicine.medical_treatment, Ankylosing Spondylitis, Cancer Treatment, Biochemistry, Etanercept, White Blood Cells, Animal Cells, Immune Physiology, Medicine and Health Sciences, 610 Medicine & health, ddc:616, Innate Immune System, Multidisciplinary, Pharmaceutics, Hazard ratio, Anti-Inflammatory Agents, Non-Steroidal, 10051 Rheumatology Clinic and Institute of Physical Medicine, Antibodies, Monoclonal, Middle Aged, C-Reactive Proteins, TNF inhibitor, Oncology, Antirheumatic Agents, Medicine, Cytokines, Female, Cellular Types, medicine.drug, Research Article, Adult, musculoskeletal diseases, medicine.medical_specialty, Drug Synthesis, Science, Immune Cells, Immunology, 1100 General Agricultural and Biological Sciences, Gastroenterology and Hepatology, Autoimmune Diseases, Drug Therapy, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, Adalimumab/administration & dosage, Anti-Inflammatory Agents, Non-Steroidal/administration & dosage, Antibodies, Monoclonal/administration & dosage, Antirheumatic Agents/administration & dosage, Etanercept/administration & dosage, Humans, Infliximab/administration & dosage, Spondylarthritis/drug therapy, Tumor Necrosis Factor Inhibitors/administration & dosage, Spondylarthritis, Adalimumab, medicine, Ankylosing spondylitis, 1000 Multidisciplinary, Blood Cells, Proportional hazards model, business.industry, Pharmaceutical Processing Technology, Inflammatory Bowel Disease, Biology and Life Sciences, Proteins, Cell Biology, Molecular Development, medicine.disease, Golimumab, Infliximab, Immune System, 570 Life sciences, biology, Clinical Immunology, Tumor Necrosis Factor Inhibitors, Clinical Medicine, business, Developmental Biology

    وصف الملف: pone.0216746.pdf - application/pdf; application/pdf

  2. 2

    المصدر: Loft, N D, Skov, L, Iversen, L, Gniadecki, R, Dam, T N, Brandslund, I, Hoffmann, H J, Andersen, M R, Dessau, R B, Bergmann, A C, Andersen, N M, Andersen, P S, Bank, S, Vogel, U & Andersen, V 2018, ' Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis ', Pharmacogenomics Journal, vol. 18, pp. 494-500 . https://doi.org/10.1038/tpj.2017.31
    Loft, N D, Skov, L, Iversen, L, Gniadecki, R, Dam, T N, Brandslund, I, Hoffmann, H J, Andersen, M R, Dessau, R B, Bergmann, A C, Møller Andersen, N, Andersen, P S, Bank, S, Vogel, U & Andersen, V 2018, ' Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis ', Pharmacogenomics Journal, vol. 18, no. 3, pp. 494–500 . https://doi.org/10.1038/tpj.2017.31
    Loft, N D, Skov, L, Iversen, L, Gniadecki, R, Dam, T N, Brandslund, I, Hoffmann, H J, Andersen, M R, Dessau, R B, Bergmann, A C, Andersen, N M, Andersen, P S, Bank, S, Vogel, U & Andersen, V 2018, ' Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis ', Pharmacogenomics Journal, vol. 18, no. 3, pp. 494-500 . https://doi.org/10.1038/tpj.2017.31

    وصف الملف: application/pdf

  3. 3
  4. 4

    المصدر: PLoS Neglected Tropical Diseases
    PLoS Neglected Tropical Diseases, Vol 11, Iss 11, p e0006059 (2017)

    مصطلحات موضوعية: 0301 basic medicine, Neurocysticercosis/complications/drug therapy/immunology/veterinary, Necrosis, Swine, Physiology, Anticestodal Agents/therapeutic use, Gene Expression, Pharmacology, Pathology and Laboratory Medicine, Dexamethasone, Praziquantel, Etanercept, chemistry.chemical_compound, 0302 clinical medicine, Pig Models, Immune Physiology, Taenia solium, Medicine and Health Sciences, Taenia solium/drug effects, Immune Response, Mammals, Swine Diseases, Innate Immune System, Antiparasitic Agents, Pharmaceutics, lcsh:Public aspects of medicine, Eukaryota, Brain, Animal Models, Interferon-gamma/genetics/immunology, Extravasation, Vascular endothelial growth factor, medicine.drug_formulation_ingredient, Infectious Diseases, Experimental Organism Systems, Blood-Brain Barrier, Vertebrates, Cytokines, Tumor necrosis factor alpha, Brain/parasitology, Etanercept/administration & dosage/adverse effects, medicine.symptom, Blood-Brain Barrier/drug effects, purl.org/pe-repo/ocde/ford#3.03.06 [https], Immunosuppressive Agents, Research Article, medicine.drug, lcsh:Arctic medicine. Tropical medicine, lcsh:RC955-962, Inflammatory Diseases, Immunology, 030231 tropical medicine, Inflammation, Research and Analysis Methods, Neurocysticercosis, Cytokines/genetics/immunology, Proinflammatory cytokine, Interferon-gamma, 03 medical and health sciences, Antiparasitic Agents/adverse effects/therapeutic use, Signs and Symptoms, Drug Therapy, Diagnostic Medicine, Dexamethasone/administration & dosage/adverse effects, parasitic diseases, Genetics, medicine, Animals, Gene Regulation, Praziquantel/administration & dosage/adverse effects/therapeutic use, Tumor Necrosis Factor-alpha, business.industry, Swine Diseases/drug therapy/immunology, Organisms, Public Health, Environmental and Occupational Health, Inflammation/prevention & control, Biology and Life Sciences, Anticestodal Agents, lcsh:RA1-1270, Molecular Development, Tumor Necrosis Factor-alpha/antagonists & inhibitors/genetics, 030104 developmental biology, chemistry, Immune System, Amniotes, business, Immunosuppressive Agents/administration & dosage/adverse effects, Developmental Biology

  5. 5